SpringWorks

$85.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:34 PM UTC today

Why Robinhood?

You can buy or sell SpringWorks and other stocks, options, and ETFs commission-free!

About SWTX

SpringWorks Therapeutics, Inc. Common Stock, also called SpringWorks, is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT. The listed name for SWTX is SpringWorks Therapeutics, Inc. Common Stock.

CEO

Saqib Islam

Employees

Headquarters

Stamford, Connecticut

Founded

2017

Market Cap

3.85B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

457.89K

High Today

$86.72

Low Today

$85.30

Open Price

$85.57

Volume

8.23K

52 Week High

$87.60

52 Week Low

$19.50

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

SWTX Earnings

-$1.77

-$1.18

-$0.59

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market